FIELD: biotechnology.
SUBSTANCE: present group of inventions relates to biotechnology and can be used in medicine and food industry. Disclosed is a modified receptor for the Fc region of immunoglobulin IgE, the glycosylation profile of which is characterized by high content of sialic acid. Dimeric polypeptide according to the present invention provides strong binding and increased half-life, is also able to inhibit the release of mediators caused by binding to Fcγ-receptor on the surface of mast cells, which enables to minimize serious adverse allergic reactions, for example, anaphylaxis.
EFFECT: polypeptide dimer with high content of sialic acid according to the present invention can be successfully used for prevention or treatment of allergic diseases.
7 cl, 20 dwg, 7 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IgE Fc RECEPTOR, A PHARMACEUTICAL COMPOSITION CONTAINING IT AND A METHOD FOR ITS PRODUCTION | 2019 |
|
RU2796162C2 |
COMPOSITION CONTAINING PROBIOTICS AND POLYPEPTIDE HAVING BINDING AFFINITY RELATIVELY TO IgE AND ITS USE | 2019 |
|
RU2786578C2 |
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION BY GLYCOENGINEERING | 2014 |
|
RU2831409C2 |
STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION | 2016 |
|
RU2740672C2 |
VERSIONS OF Fc-REGION WITH ALTERED BINDING TO NEONATAL Fc-RECEPTOR (FcRn) FOR USE IN VETERINARY SCIENCE | 2019 |
|
RU2830231C2 |
IMMUNOGLOBULIN CONSTANT REGION FC-RECEPTOR BINDING AGENTS | 2008 |
|
RU2729829C2 |
FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2012 |
|
RU2698655C2 |
Fc FUSION HIGH AFFINITY IgE RECEPTOR α-CHAIN | 2016 |
|
RU2715606C2 |
FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2019 |
|
RU2728861C1 |
COMPOSITION FOR CULTURING REGULATORY T-CELLS AND ITS APPLICATION | 2020 |
|
RU2807802C1 |
Authors
Dates
2025-01-27—Published
2020-07-07—Filed